obesity | CARLAT PUBLISHING

Q&A

Overview of Psychological Assessment Before Bariatric Surgery

December 5, 2022

A constellation of factors contributes to successful outcomes in weight loss surgery and one of them is a thorough assessment.

Treating Common Medical Conditions in Patients With Chronic Mental Illnesses

July 1, 2022

Lauren-Alyssa Wake, DO and Shazadie Soka, MD

Shazadie Soka, MD. Chief resident, Wayne State University Department of Psychiatry, Detroit, MI. Lauren-Alyssa Wake, DO. Inpatient psychiatrist, Trinity Health, Minot, ND. Dr. Soka and Dr. Wake have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We spend years learning how to treat psychiatric illnesses, so it can feel uncomfortable to treat nonpsychiatric conditions like urinary tract infections. But as medical providers, we want to optimize our patients’ health outcomes, especially since we are often the only clinicians they have easy access to. Here we review uncomplicated medical conditions that we frequently see among patients with chronic mental illnesses.

Lybalvi: The Diet Olanzapine

January 31, 2022

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.

Lybalvi hopes to lower the risk of weight gain on olanzapine by combining it with an opioid blocker (samidorphan). But how does it compare to generic options like metformin and naltrexone?

EXPERT Q&A

Probiotics in Psychiatry

December 31, 2020

Ted Dinan, MD, PhD

Ted Dinan, MD, PhD
Professor of psychiatry at University College Cork, Ireland. Dr. Dinan’s research focuses on depression, irritable bowel syndrome, and the influence of the gut microbiota on brain function. He has published over 500 scientific papers and numerous books, including 2019’s The Psychobiotic Revolution. Dr. Dinan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The gut microbiome is one of the newest entries in the list of causes of depression. Ted Dinan explains how the bacteria in the GI tract influence the brain, and whether a probiotic or a lifestyle change is the best way to address it.

Ketamine and Obesity [60 Sec Psych]

May 20, 2020

Obesity is rarely a harbinger of recovery with antidepressant therapy, but at least 3 treatments may be exceptions to that rule. A review of Freeman MP, Hock RS, Papakostas GI, et al. Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder. J Clin Psychopharmacol.

EXPERT Q&A

Inflammatory Biomarkers in Depression

February 10, 2020

Andrew H. Miller, MD

Andrew H. Miller, MD

William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University, GA Dr. Miller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Andrew Miller, Vice Chair of Psychiatry Research at Emory University, translates two decades research on inflammation and depression into practical terms, including a low-cost biomarker that may guide antidepressant selection.